The results shown in Figures S1C and S1D further support the activation of a GCN2/ATF4-dependent, but CHOP-independent, signaling pathway that drives IL-8 upregulation in glutamine-deprived HCT116 tumor cells. The gene discussed is DDIT3; the disease is neoplasm.